Skip to main content

Table 3 CMR characteristics of patients without fibrosis at baseline

From: Left ventricular reverse remodeling after transcatheter aortic valve implantation: a cardiovascular magnetic resonance study

 

Baseline

Sixmonths

P

 

N= 17

N= 17

 

LVEF (%)

63.9±14.6

67.6±76.5

0.15

LVEDV (ml)

152.7±57.5

154.7±44.2

0.82

LVEDVi (ml/m2)

87.1±35

87.0±25.2

0.99

LVESV (ml)

60±48.8

51.1±22.7

0.27

LVESVi (ml/m2)

34.5±29

28.9±13.4

0.25

LVM (g)

148.0±50.4

124.7±41.8

0.000

LVMi (g/m2)

83.9±28.9

69.5±22.3

0.000

Stroke volume (ml)

90.9±20

98.5±28

0.57

CardiacOutput (L/min)

5.9±1.3

6.2±1.3

0.98

  1. CMR cardiovascular magnetic resonance; LVEDVi indexed left ventricular end diastolic volume; LVESVi indexed left ventricular end systolic volume; LVMi indexed left ventricular mass; LVEDV left ventricular end diastolic volume; LVEF left ventricular ejection fraction; LVM left ventricular mass; LVESV left ventricular end systolic volume.